ACE and metabolic syndrome: The uses of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEIs/ARBs), calcium channel blockers (CCBs), β-blockers, and statins were also significantly associated with the presence of CAD statistically; however, the following parameters were dependent on each other; fasting blood glucose and diabetes mellitus, lipid profile and dyslipidemia, and eGFR and renal dysfunction.